$99.00
Cagrilintide 5mg is a long-acting amylin analogue research peptide studied for amylin receptor activity, appetite regulation, gastric-emptying models, glucose metabolism, and metabolic research. For laboratory research use only.
Cagrilintide 5mg is a synthetic long-acting amylin analogue research peptide studied for amylin receptor signalling, appetite-regulation pathways, gastric-emptying models, glucose metabolism, and broader metabolic research. It is also known by the development code AM833 and has been investigated both as a standalone compound and in combination with semaglutide in CagriSema-related research. Scientific literature describes cagrilintide as a long-acting amylin analogue being developed for obesity-related metabolic studies.
CAS No.: 1415456-99-3. CAS references may vary by supplier or salt/intermediate form, so the batch COA should be checked before publishing.
This product is intended for laboratory research use only and is not for human consumption, clinical use, veterinary use, or diagnostic applications.
